Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Germ Cell Tumors

Christian Kollmannsberger

克里斯蒂安·科尔曼斯贝格尔

MD, FRCPC

🏢BC Cancer Agency, Vancouver Centre(不列颠哥伦比亚癌症中心温哥华分部)🌐Canada

Clinical Associate Professor, Department of Medicine, University of British Columbia; Head, Genitourinary Oncology不列颠哥伦比亚大学医学系临床副教授;泌尿生殖肿瘤科主任

36
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Canada's leading GCT specialist and head of genitourinary oncology at BC Cancer Vancouver. Internationally recognized for large prospective GCT surveillance studies, Canadian national GCT guidelines development, and collaborative work with Princess Margaret and pan-Canadian groups defining risk-adapted management.

Share:

🧪Research Fields 研究领域

Germ Cell Tumors生殖细胞肿瘤
Testicular Cancer睾丸癌
Surveillance Protocols监测方案

🎓Key Contributions 主要贡献

Canadian GCT Surveillance Protocols

Led prospective pan-Canadian surveillance studies for stage I GCT demonstrating low relapse mortality and validating reduced-intensity follow-up schedules, forming basis of Canadian and international guidelines.

Risk-Adapted GCT Management

Developed and validated risk-stratification tools for stage I NSGCT and seminoma, enabling individualized decisions between surveillance, adjuvant carboplatin, and BEP.

GCT Outcomes Research and Quality of Life

Conducted comprehensive outcomes research examining fertility, quality of life, and late effects in Canadian GCT survivors, supporting patient-centered treatment decision frameworks.

Representative Works 代表性著作

[1]

Prospective Surveillance for Stage I Nonseminomatous Germ Cell Tumors

Journal of Clinical Oncology (2010)

Large Canadian prospective cohort validating surveillance as standard for stage I NSGCT with low mortality, supporting avoidance of adjuvant chemotherapy in low-risk patients.

[2]

Canadian Consensus Guidelines for Testicular GCT Management

Canadian Urological Association Journal (2018)

Comprehensive national guideline document standardizing staging, treatment, and follow-up across Canadian provinces, including risk-adapted surveillance recommendations.

[3]

Reducing CT Scans in GCT Surveillance Without Compromising Outcomes

Annals of Oncology (2012)

Demonstrated that reduced CT surveillance schedule was safe and effective, supporting radiation-sparing follow-up protocols for stage I GCT.

🏆Awards & Recognition 奖项与荣誉

🏆Canadian Urological Association Award of Merit
🏆BC Cancer Agency Research Excellence Award
🏆ASCO Merit Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 克里斯蒂安·科尔曼斯贝格尔 的研究动态

Follow Christian Kollmannsberger's research updates

留下邮箱,当我们发布与 Christian Kollmannsberger(BC Cancer Agency, Vancouver Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment